NO APLICA

Conservative Management of Retained Products of Conception with Combined Oral Contraceptives. Case Report

no aplica

 

---

Visão geral 2293 | Visualizações de PDF 40

---

Downloads

Os dados de download ainda não estão disponíveis.

1. Debby A, Malinger E, Harow E, Golan A, Glezerman M. Transvaginal ultrasound after first-trimester uterine evacuation reduces the incidence of retained products of conception. Ultrasound Obstet Gynecol. 2006; 27(1):61-64. DOI: 10.1002/uog.2654
2. , Ben-Ami I, Melcer Y, Smorgick N, Schneider D, Pansky M, Halperin R. A comparison of reproductive outcomes following hysteroscopic management versus dilatation and curettage of retained products of conception, Int J Gynecol Obstet. 2014; 127(1):86-89. http://dx.doi.org/10.1016/j.ijgo.2014.05.003
3. Hooker AB, Aydin H, Brôlmann HA, Huirne JA. Long term complications and reproductive outcome after the management of retained products of conception: a systematic review. Fertility and Sterility. 2016; 105(1):156-164. https://doi.org/10.1016/j.fertnstert.2015.09.021
4. Klement AH, Frederic M, Bentov Y, Chang P, Nayot D, Haas J, et al. Oral contraceptive pills as an option for non-surgic al management of retained products of conception-a preliminary study. Gynecol Endocrinol. 2018; 34(7):609-611. DOI: 10.1080/09513590.2018.1427714
5. Jimenez JS, Gonzalez C, Alvarez C, Muñoz L, Perez C, Muñoz J. Conservative management of retained trophoblastic tissue and placental polyp with diagnostic ambulatory hysteroscopy. Eur J Obstet Gynecol Reprod Biol. 2009; 145(1): 89–92. https://doi.org/10.1016/j.ejogrb.2009.04.001
6. Harish KM, Shwetha N, Dipankar D. Comparative análisis of hysteroscopy versus suction evacuation in the management of retained products of conception. Int J Reprod Contracept Obstet Gynecol. 2018; 7(6):2155-2159. http://dx.doi.org/10.18203/2320-1770.ijrcog20182009
7. Sellmyer MA, Desser TS, Maturen KE, Jeffrey RB, Kamaya A. Physiologic, Histologic, and Imaging Features of Retained Products of Conception. Radiographics. 2013; 33(3):781-796. DOI: 10.1148/rg.333125177
8. Casikar I, Bignardi T, Riemke J, Alhamdan D, Condous G. Expectant management of spontaneous first-trimester miscarriage: pospective validation of the “2 weeks rule”. Ultrasound Obstet Gynecol. 2010; 35(2): 223–227. DOI: 10.1002/uog.7486
9. Trinder J, Brocklehurst P, Porter R, Read M, Vyas S, Smith L. Management of miscarriage: expectant, medical, or surgical? Results of randomised controlled trial (miscarriage treatment (MIST) trial). BMJ. 2006; 332(7552):1235-1240. DOI: 10.1136/bmj.38828.593125.55
10. Barnhart K, Sammel MD, Chung K, Zhou L, Hummel AC, Guo W. Decline of Serum Human Chorionic Gonadotropin and Spontaneous Complete Abortion: defining the Normal Curve. Obstet Gynecol. 2004; 104(5) 975-981. DOI: 10.1097/01.AOG.0000142712.80407.fd
11. Pocius KD, Maurer R, Fortin J, Goldberg AB, Bartz D. Early serum human chorionic gonadotropin (hCG) trends after medication abortion. Contraception. 2015; 91(6): 503–506. DOI: 10.1016/j.contraception.2015.03.004
12. Pourali L, Ayati S, Layegh P, Vatanchi A, Rastin Z, Shourvi A. Persistent low levels of Beta-hCG: a pitfall in diagnosis of Retained products of Conception. Acta Med Iran. 2018; 56(7):478-481.
13. Tohma YA, Dilbaz B, Evliyaoğlu O, Çoşkun B, Çolak E, Dilbaz S. Is ultrasonographic evaluation essential for diagnosis of retained products of conception after surgical abortion? J Obstet Gynaecol Res. 2016; 42(5):489-495. https://doi.org/10.1111/jog.12944
14. Reeves MF, Fox MC, Lohr PA, M. D. Creinin MD. Endometrial thickness following medical abortion is not predictive of subsequent surgical intervention. Ultrasound Obstet Gynecol. 2009; 34(1):104–109. DOI: 10.1002/uog.6404
15. Sawyer E, Ofuasia E, Ofili-Yebovi D, Helmy S, Gonzalez J, Jurkovic D. The value of measuring endometrial thickness and volumen on transvaginal ultrasound scan for the diagnosis of incomplete miscarriage. Ultrasound Obstet Gynecol. 2007; 29(2):205–209. DOI: 10.1002/uog.3914
16. Chopra N, Kaur M, Kaur-Mohi M. Correlation of ultrasound with histopathology for retained products of conception in medically managed abortions. Int J Reprod Contracept Obstet Gynecol. 2017; 6(8):3372-3375. http://dx.doi.org/10.18203/2320-1770.ijrcog20173373
17. Hameed BH. Incomplete miscarriage, expectant versus medical management and the use of Doppler sonography for patient selection. Iraqi J Comm Med. 2016; 2:10-15.
18. Van den Bosch T, Van Schoubroeck D, Timmerman D. Maximum Peak Systolic Velocity and Management of Highly Vascularized Retained Products of Conception. J Ultrasound Med. 2015; 34(9):1577–1582. DOI: 10.7863/ultra.15.14.10050
19. Betel C, Atri M, Arenson AM, Khalifa M, Osborne R, Tomlinson G. Sonographic Diagnosis of Gestational Trophoblastic Disease and Comparison With Retained Products of Conception. J Ultrasound Med. 2006; 25(8):985–993. DOI: 10.7863/jum.2006.25.8.985
20. Jain K, Fogata M. Retained Products of Conception Mimicking a Large Endometrial AVM: Complete Resolution Following Spontaneous Abortion. J Ultrasound Med. 2007; 35(1):42-47. DOI: 10.1002/jcu.20250
21. Vilos AG, Vilos GA, Hollett-Caines J, Rajakumar C, Garvin G, Kozack R. Uterine artery embolization for uterine arteriovenous malformation in five women desiring fertility: pregnancy outcomes. Hum Reprod. 2015; 30(7):1599–1605. DOI: 10.1093/humrep/dev097
22. Hashim H, Nawawi O. Uterine arteriovenous malformation. Malays J Med Sci. 2013; 20(2):76-80.
23. Kim C, Barnard S, Neilson JP, Hickey M, Vazquez JC, Dou L. Medical treatments for incomplete miscarriage. Cochrane Database Syst Rev. 2017; 1:1-2. DOI: 10.1002/14651858.CD007223.pub4
24. Lemmers M, Verschoor MA, Regenrink KO, Naaktgeboren C, Opmeer BC, Bossuyt PM, et al. MisoREST: surgical versus expectant management in women with an incomplete evacuation of the uterus after misoprostol treatment for miscarriage: a randomized controlled trial. Hum Reprod. 2016; 31(11):2421-2427. DOI:10.1093/humrep/dew221
25. Kaviani M, Tehrani TA, Azima S, Abdali K, Asadi N. Comparison of the Effects of Simultaneous Use of Methylergonovine and Combined Low-dose (LD) Contraceptive Pills on Hemorrhage Due to Retained Pregnancy Products after Abortion. Int J Curr Microbiol App Sci. 2016; 5(11):499-507. http://dx.doi.org/10.20546/ijcmas.2016.511.058
26. Lethaby A, Wise MR, Weterings MA, Bofill-Rodriguez M, Brown J. Combined hormonal contraceptives for heavy menstrual bleeding. Cochrane Database Syst Rev. 2019;2:1-3. DOI: 10.1002/14651858.CD000154.pub3
27. Martin CW, Brown AH, Baird DT. A pilot study of the effect of methotrexate or combined oral contraceptive on bleeding patterns after induction of abortion with mifepristone and a prostaglandin pessary. Contraception. 1998; 58(2):99-103. DOI: 10.1016/s0010-7824(98)00072-9
28. Smorgick N, Barel O, Fuchs N, Ben-Ami I, Pansky M, Vaknin Z. Hysteroscopic management of retained products of conception: meta-analysis and literature review. Eur J Obstet Gynecol Reprod Biol. 2014; 173:19–22. https://doi.org/10.1016/j.ejogrb.2013.11.020